Trans-plasma membrane electron transport in mammals: Functional significance in health and disease

Antioxidants and Redox Signaling

Volumn 14, Issue 11, 2011, Pages 2289-2318

  Principe, Domenico Del ^a,b   Avigliano, Luciana ^a   Savini, Isabella ^a   Catani, Maria Valeria ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Istituto San Raffaele   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME B; CYTOCHROME B5 REDUCTASE; DISULFIDE; DUODENAL CYTOCHROME B; DUOX 1 ENZYME; DUOX 2 ENZYME; NOX 1 ENZYME; NOX 2 ENZYME; NOX 3 ENZYME; NOX 4 ENZYME; PROTON PUMP; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOL; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL;

AGING; ANTIBODY RESPONSE; APOPTOSIS; ASTHMA; AUTOPHAGY; CARDIOVASCULAR DISEASE; CELL DEATH; CELL MEMBRANE; DEGENERATIVE DISEASE; DIABETES MELLITUS; ELECTRON; ELECTRON ACCEPTOR; ELECTRON CARRIER; ELECTRON DONOR; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME STRUCTURE; FERTILIZATION; HOMEOSTASIS; HUMAN; LUNG FIBROSIS; MAMMAL; METABOLIC SYNDROME X; MOLECULAR DYNAMICS; NEOPLASM; NONHUMAN; OBESITY; OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SPERMATOZOON MATURATION; STRUCTURE ANALYSIS; THROMBOCYTE; TRANS PLASMA MEMBRANE ELECTRON TRANSPORT;

AGING; ANIMALS; APOPTOSIS; ASTHMA; AUTOPHAGY; CARDIOVASCULAR DISEASES; CELL MEMBRANE; CYTOCHROME REDUCTASES; CYTOCHROMES B; ELECTRON TRANSPORT; FERTILIZATION; HOMEOSTASIS; HUMANS; MAMMALS; METABOLIC DISEASES; NADH, NADPH OXIDOREDUCTASES; NEOPLASMS; NEURODEGENERATIVE DISEASES; PULMONARY FIBROSIS; SPERMATOGENESIS; VOLTAGE-DEPENDENT ANION CHANNELS;

MAMMALIA;

EID: 79956073475     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2010.3247     Document Type: Review

References (323)

1. Abdala-Valencia H, Earwood J, Bansal S, Jansen M, Babcock G, Garvy B, Wills-Karp M, and Cook-Mills JM. Nonhematopoietic NADPH oxidase regulation of lung eo-sinophilia and airway hyperresponsiveness in experimen-tally induced asthma. Am J Physiol Lung Cell Mol Physiol 292: L1111-L1125, 2007. (Pubitemid 47084855)
2. Abo A, Boyhan A, West I, Thrasher AJ, and Segal AW. Reconstitution of neutrophil NADPH oxidase activity in the cell-free system by four components: p67-phox, p47-phox, p21 racl and cytochrome b-245. J Biol Chem 267: 16767-16770, 1992.
3. Adams V, Linke A, Krankel N, Erbs S, Gielen S, Mobius-Winkler S, Gummert JF, Mohr FW, Schuler G, and Ham-brecht R. Impact of regular physical activity on the NAD(P)H oxidase and angiotensin receptor system in pa-tients with coronary artery disease. Circulation 111: 555-562, 2005. (Pubitemid 40216482)
4. Adrain C and Martin SJ. The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci 26: 390-397, 2001. (Pubitemid 32530658)
5. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, and Iida M. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109: 227-233, 2004. (Pubitemid 38114144)
6. Aitken RJ and Baker MA. Oxidative stress and male re-productive biology. Reprod Fert Dev 16: 581-588, 2004. (Pubitemid 39172890)
7. Akanda N, Tofighi R, Brask J, Tamm C, Elinder F, and Ceccatelli S. Voltage-dependent anion channels (VDAC) in the plasma membrane play a critical role in apoptosis in differentiated hippocampal neurons but not in neural stem cells. Cell Cycle 7: 3225-3234, 2008.
8. Amer J and Fibach E. Oxidative status of platelets in nor-mal and thalassemic blood. Thromb Haemost 92: 1052-1059, 2004. (Pubitemid 39545529)
9. Amer J, Ghoti H, Rachmilewitz E, Koren A, Levin C, and Fibach E. Red blood cells, platelets and polymorphonuclear neutrophils of patients with sickle cell disease exhibit oxi-dative stress that can be ameliorated by antioxidants. Br J Haematol 132: 108-113, 2006. (Pubitemid 43381577)
10. 2+-dependent H2O2-gen-erating activity. J Biol Chem 280: 30046-30054, 2005. (Pubitemid 41216180)
11. Arrigoni O, Dipierro S, and Borraccino G. Ascorbate free radical reductase, a key enzyme of the ascorbic acid system FEBS Lett 125: 242-244, 1981.
12. Arroyo A, Kagan VE, Tyurin VA, Burgess JR, de Cabo R, Navas P, and Villalba JM. NADH and NADPH-dependent reduction of coenzyme Q at the plasma membrane. Anti-oxid Redox Signal 2: 251-262, 2000. (Pubitemid 30445937)
13. Asher G, Bercovich Z, Tsvetkov P, Shaul Y, and Kahana C. 20S proteasomal degradation of onithine decarboxylase is regulated by NQO1. Mol Cell 17: 645-655, 2005. (Pubitemid 40320915)
14. Asher G, Tsvetkov P, Kahana C, and Shaul Y. A mechanism of ubiquitin-independent proteasomal degradation of the tumour suppressor p53 and p73. Genes Dev 19: 316-321,2005. (Pubitemid 40189294)
15. Avigliano L, Savini I, Catani MV, and Del Principe D. Trans-plasma membrane electron transport in human blood platelets. Mini Rev Med Chem 8: 555-563, 2008.
16. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, and Molk-entin JD. Voltage-dependent anion channels are dispens-able for mitochondrial-dependent cell death. Nat Cell Biol 9: 550-555, 2007. (Pubitemid 46696536)
17. Baker MA and Aitken RJ. The importance of redox regu-lated pathways in sperm cell biology. Mol Cell Endocrinol 216: 47-54, 2004. (Pubitemid 38520917)
18. Baker MA, Krutskikh A, Curry BJ, Hetherington L, and Aitken RJ. Identification of cytochrome b5-reductase as the enzyme responsible for NADH-dependent lucigenin che-miluminescence in human spermatozoa. Biol Reprod 73: 334-342, 2005. (Pubitemid 41022793)
19. Baker MA, Krutskikh A, Curry BJ, McLaughlin EA, and Aitken RJ. Identification of cytochrome p450-reductase as the enzyme responsible for NADPH-dependent lucigenin and tetrazolium salt reduction in rat epididymal sperm preparations. Biol Reprod 71: 307-318, 2004. (Pubitemid 38915338)
20. Baker MA, Lane DJ, Ly JD, De Pinto V, and Lawen A. VDAC1 is a transplasma membrane NADH-ferricyanide reductase. J Biol Chem 279: 4811-4819, 2004. (Pubitemid 38199076)
21. Baker MA, Reeves G, Hetherington L, Müller J, Baur I, and Aitken RJ. Identification of gene products present in Triton X-100 soluble and insoluble fractions of human spermato-zoa lysates using LC-MS/MS analysis. Proteomics Clin Appl 1: 524-532, 2007.
22. Balusikova K, Neubauerova J, Dostalikova-Cimburova M, Horak J, and Kovar J. Differing expression of genes in-volved in non-transferrin iron transport across plasma membrane in various cell types under iron deficiency and excess. Mol Cel Biochem 321: 123-133, 2009.
23. Banfi B, Molnar G, Maturana A, Steger K, Hegedus B, Demaurex N, and Krause KH. A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes. J Biol Chem 276: 37594-37601, 2001.
24. 2+ activation of the NADPH oxidase 5 (NOX5). J Biol Chem 279: 18583-18591, 2004. (Pubitemid 38623279)
25. Baoutina A, Dean RT, and Jessup W. Trans-plasma mem-brane electron transport induces macrophage-mediated low density lipoprotein oxidation. FASEB J 15: 1580-1582, 2001.
26. Bayrhuber M, Meins T, Habeck M, Becker S, Giller K, Villinger S, Vonrhein C, Griesinger C, Zweckstetter M, and Zeth K. Structure of the human voltage-dependent an-ion channel. Proc Natl Acad SciU SA 105:15370-15375,2008.
27. Benz R. Permeation of hydrophilic solutes through mito-chondrial outer membranes: Review on mitochondrial porins. Biochim Biophys Acta 1197: 167-196, 1994.
28. Berridge MV and Tan AS. Cell surface NAD(P)H-oxidase: relationship to transplasma membrane NADH-oxidoreductase and a potential source of circulating NADH-oxidase. Antioxid Redox Signal 2: 277-288, 2000. (Pubitemid 30445939)
29. Berridge MV and Tan AS. High-capacity redox control at the plasma membrane of mammalian cells: trans-membrane, cell surface, and serum NADH-oxidases. Antioxid Redox Signal 2: 231-242, 2000. (Pubitemid 30445935)
30. Berridge MV and Tan AS. Trans-plasma membrane electron transport: a cellular assay for NADH-and NADPH-oxidase based on extracellular, superoxide-mediated reduction of the sulfonated tetrazolium salt WST-1. Protoplasma 205: 74-82, 1998. (Pubitemid 29053951)
31. Berridge MV, Herst PM, and Lawen A. Targeting mito-chondrial permeability in cancer drug development. Mol Nutr Food Res 53: 76-86, 2009.
32. Berridge MV, Herst PM, and Tan AS. Tetrazolium dyes as tools in cell biology: new insights into their cellular re-duction. Biotechnol Annu Rev 11: 127-152, 2005. (Pubitemid 41510276)
33. Bewley MC, Marohnic CC, and Barber MJ. The structure and biochemistry of NADH-dependent cytochrome b5 re-ductase are now consistent. Biochemistry 40: 13574-13582, 2001. (Pubitemid 33130785)
34. Bianchet MA, Faig M, and Amzel LM. Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO). Methods Enzymol 382: 144-174, 2004. (Pubitemid 38240789)
35. Björnstedt M, Nordman T, and Olsson JM Extra-mitochondrial reduction of ubiquinone by flavoenzymes. Methods Enzymol 378: 131-138, 2004.
36. Block ML. NADPH oxidase as a therapeutic target in Alz-heimer's disease. BMC Neurosci 9: S8-S15, 2008.
37. Bokoch GM, Diebold B, Kim JS, and Gianni D. Emerging evidence for the importance of phosphorylation in the regulation of NADPH oxidases. Antioxid Redox Signal 11: 2429-2441, 2009.
38. Borgese N, Macconi D, Parola L, and Pietrini G. Rat erythrocyte NADH-cytochrome b5 reductase. J Biol Chem 257: 13854-13861, 1982.
39. Borraccino G, Dipierro S, and Arrigoni O. Purification and properties of ascorbate free-radical reductase from potato tubers. Planta 167: 521-526, 1986.
40. Brenner C and Grimm S. The permeability transition pore complex in cancer cell death. Oncogene 25: 4744-4756, 2006. (Pubitemid 44192088)
41. Brightman AO, Wang J, Miu RK, Sun IL, Barr R, Crane FL, and Morré DJ. A growth factor-and hormone-stimulated NADH oxidase from rat liver plasma membrane. Biochim Biophys Acta 1105: 109-117, 1992.
42. Brown DI and Griendling KK. Nox proteins in signal transduction. Free Radic Biol Med 47: 1239-1253, 2009.
43. Bruce-Keller AJ, Gupta S, Parrino TE, Knight AG, Ebenezer PJ, Weidner AM, Levine H, Keller JN, and Markesbery WR. NOX activity is increased in mild cognitive impairment. Antioxid Redox Signal 12: 1371-1382, 2010.
44. Buettner R, Papoutsoglou G, Scemes E, Spray DC, and Dermietzel R Evidence for secretory pathway localization of a voltage-dependent anion channel isoform. Proc Natl Acad Sci USA 97: 3201-3206, 2000. (Pubitemid 30183279)
45. Campanella ME, Chu H, and Low PS. Assembly and reg-ulation of a glycolytic enzyme complex on the human erythrocyte membrane. Proc Natl Acad SciUSA 102: 2402-2407, 2005. (Pubitemid 40279388)
46. Chamulitrat W, Schmidt R, Tomakidi P, Stremmel W, Chunglok W, Kawahara T, and Rokutan K. Association of gp91phox homolog Nox1 with anchorage-independent growth and MAP kinase-activation of transformed human keratinocytes. Oncogene 22: 6045-6053, 2003. (Pubitemid 37175882)
47. Chen CF, Huang S, Liu SC, and Chueh PJ. Effect of poly-clonal antisera to recombinant tNOX protein on the growth of transformed cells. Biofactors 28: 119-133, 2006. (Pubitemid 47010943)
48. Cheng G and Lambeth JD. NOXO1, regulation of lipid binding, localization, and activation of Nox1 by the Phox homology (PX) domain. J Biol Chem 279: 4737-4742, 2004. (Pubitemid 38199068)
49. Cheng G, Cao Z, Xu X, van Meir EG, and Lambeth JD. Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001. (Pubitemid 32488913)
50. Cheng G, Diebold BA, Hughes Y, and Lambeth JD. Nox1-dependent reactive oxygen generation is regulated by Rac1. J Biol Chem 281: 17718-17726, 2006. (Pubitemid 44035570)
51. Cho NM, Chueh P-J, Kim C, Caldwell S, Morré DM, and Morré DJ. Monoclonal antibody to a cancerspecific and drug-responsive hydroquinone (NADH) oxidase from the sera of cancer patients. Cancer Immunol Immunother 51: 121-129, 2002. (Pubitemid 34298107)
52. Chueh P-J, Kim C, Cho N, Morré DM, and Morré DJ. Molecular cloning and characterization of a tumor-associated, growth-related and time-keeping hydroquinone (NADH) oxidase (NOX) of the HeLa cell surface. Biochemistry 41: 3732-3741,2002. (Pubitemid 34224687)
53. Chueh P-J, Morré DM, and Morré DJ. A site directed mu-tagenesis analysis of tNOX functional domains. Biochim Biophys Acta 1594: 74-83, 2002. (Pubitemid 34131727)
54. Chueh PJ, Wu LY, Morré DM, and Morré DJ. tNOX is both necessary and sufficient as a cellular target for the anti-cancer actions of capsaicin and the green tea catechin (-)-epigallocatechin-3-gallate. Biofactors 20: 235-249, 2004.
55. Cimen MY. Free radical metabolism in human erythro-cytes. Clin Chim Acta 390: 1-11, 2008.
56. Clark RA, Volpp BD, Leidal KG, and Nauseef WM. Trans-location of cytosolic components of neutrophil NADPH ox-idase. Trans Assoc Am Physicians 102: 224-230, 1989.
57. Colombini M. Structure and mode of action of a voltage dependent anion-selective channel (VDAC) located in the outer mitochondrial membrane. Ann N Y Acad Sci 341: 552-563, 1980.
58. Correll CC, Batie CJ, Ballou DP, and Ludwig ML. Phthalate dioxygenase reductase: a modular structure for electron transfer from pyridine nucleotides to [2Fe-2S]. Science 258: 1604-1610, 1992. (Pubitemid 23012435)
59. Crane FL and Löw H. NADH oxidation in liver and fat cell plasma membranes. FEBS Lett 68: 153-156, 1976.
60. Crane FL and Löw H. Reactive oxygen species generation at the plasma membrane for antibody control. Autoimmun Rev 7: 518-522, 2008.
61. Crane FL, Sun IL, Clark MG, Grebing C, and Löw H. Transplasma-membrane redox systems in growth and de-velopment. Biochim Biophys Acta 811: 233-264, 1985. (Pubitemid 15246564)
62. Crane FL, Sun IL, Crowe R, and Löw H. Electron and proton transport across the plasma membrane. J Bioenerg Biomemb 23: 773-803, 1991.
63. Crane FL, Sun IL, Crowe, RA, and Löw H. Oxidase control of plasma membrane proton transport. In: Principles of Medical Biology: 4, Cell Chemistry and Physiology, Part III, edited by Bittar EE and Bittar N. Greenwich, CT: JAI Press, 1996, pp. 169-186.
64. Crane FL. Biochemical functions of coenzyme Q10. J Am Coll Nutr 20: 591-598, 2001.
65. Crane FL. The evolution of coenzyme Q. BioFactors 32: 5-11, 2008.
66. Cui W, Matsuno K, Iwata K, Ibi M, Katsuyama M, Kakehi T, Sasaki M, Ikami K, Zhu K, and Yabe-Nishimura C. NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models. J Phar-macol Sci 111: 260-268, 2009.
67. Cullen JJ, Hinkhouse MM, Grady M, Gaut AW, Liu J, Zhang YP, Darby Weydert CJ, Domann FE, and Oberley LW. Dicoumarol inhibition of NAD(P)H quinone oxidore-ductase induces growth inhibition of pancreatic cancer via a superoxide mediated mechanism. Cancer Res 63: 5513-5520, 2003. (Pubitemid 37139871)
68. Dalton DA, Langeberg L, and Robbins M. Purification and characterization of monodehydroascorbate reductase from soybean root nodules. Arch Biochem Biophys 292: 281-286, 1992.
69. De Cabo R, Cabello R, Rios M, Lopez-Lluch G, Ingram DK, Lane MA, and Navas P. Calorie restriction attenuates age-related alterations in the plasma membrane antioxidant system in rat liver. Exp Gerontol 39: 297-304, 2004. (Pubitemid 38264360)
70. De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE, and Miot F. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275: 23227-23233, 2000. (Pubitemid 30646220)
71. De Laurenzi V, Melino G, Savini I, Annichiarico-Petruzzelli M, Finazzi-Agrò A, and Avigliano L. Cell death by oxida-tive stress and ascorbic acid regeneration in human neu-roectodermal cell lines. Eur J Cancer 31: 463-466, 1995.
72. De Luca T, Bosneaga E, Morré DM, and Morré DJ. Downstream targets of altered sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol. Biofactors 34: 253-260, 2009.
73. De Luca T, Morré DM, Zhao H, and Morré DJ. NAD+/NADH and/or CoQ/CoQH2 ratios from plasma membrane electron transport may determine ceramide and sphingosine-1-phosphate levels accompanying G1 arrest and apoptosis. Biofactors 25: 43-60, 2005. (Pubitemid 44070832)
74. De Pinto V, Messina A, Lane DJ, and Lawen A. Voltage-dependent anion-selective channel (VDAC) in the plasma membrane. FEBS Lett 584: 1793-1799, 2010.
75. Dedov VN, Mandadi S, Armati PJ, and Verkhratski A. Capsaicin-induced depolarization of mitochondria in dor-sal root ganglion neurons is enhanced by vanilloid recep-tors. Neuroscience 103: 219-226, 2001. (Pubitemid 32304361)
76. Del Principe D, Frega G, Savini I, Catani MV, Rossi A, and Avigliano L. The plasma membrane redox system in human platelet functions and platelet-leukocyte interac-tions. Thromb Haemost 101: 284-289, 2009.
77. Del Principe D, Mancuso G, Menichelli A, Gabriotti M, Cosmi EV, and Gherardi G. Production of hydrogen perox-ide in phagocyting human platelets: an electron microscopic cytochemical demonstration. Biol Cell 38: 135-140, 1980. (Pubitemid 10023442)
78. del Valle AE, del Castillo-Olivares A, Sanchez-Jimenez F, Marquez J, Nunez de Castro I, and Medina MA. Plasma membrane redox system activity in tumour cell lines of mammary origins with different proliferation rates. Proto-plasma 205: 169-173, 1998. (Pubitemid 29053962)
79. Dinauer MC, Orkin SH, Brown R, Jesaitis AJ, and Parkos CA. The glycoprotein encoded by the X-linked chronic granulomatous disease locus is a component of the neutrophil cytochrome b complex. Nature 327: 717-720, 1987. (Pubitemid 17085906)
80. Dinauer MC, Pierce EA, Bruns GAP, Cumutte JT, and Orkin SH. Human neutrophil cytocrome-b light chain (p22-phox): Gene structure, chromosomal location, and muta-tions in cytochrome negative autosomal recessive chronic granulomatous disease. J Clin Invest 86: 1729-1737, 1990. (Pubitemid 20372627)
81. Dringen R, Pfeiffer B, and Hamprecht, B. Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. JNeurosci 19: 562-569, 1999. (Pubitemid 29036007)
82. Du M, Shirabe K, and Takeshita M. Identification of alter-native first exons of NADH-cytochrome b5 reductase gene expressed ubiquitously in human cells. Biochem Biophys Res Commun 235: 779-783, 1997. (Pubitemid 27326561)
83. Dusi S, Donini M, Lissandrini D, Mazzi P, Bianca VD, and Rossi F. Mechanisms of expression of NADPH oxidase components in human cultured monocytes: role of cyto-kines and transcriptional regulators involved. Eur J Im-munol 31: 929-938, 2001. (Pubitemid 32237129)
84. Elinder F, Akanda N, Tofighi R, Shimizu S, Tsujimoto Y, Orrenius S, and Ceccatelli S. Opening of plasma membrane voltage-dependent anion channels (VDAC) precedes cas-pase activation in neuronal apoptosis induced by toxic stimuli. Cell Death Differ 12: 1134-1140, 2005. (Pubitemid 41065430)
85. Fernández-Ayala DJ, Brea-Calvo G, López-Lluch G, and Navas P. Coenzyme Q distribution in HL-60 human cells depends on the endomembrane system. Biochim Biophys Acta 1713: 129-137, 2005. (Pubitemid 40961626)
86. Fiorani M and Accorsi A. Dietary flavonoids as intracellu-lar substrates for an erythrocyte trans-plasma membrane oxidoreductase activity. Br J Nutr 94: 338-345, 2005. (Pubitemid 41404276)
87. Fischer H. Mechanisms and function of DUOX in epithelia of the lung. Antioxid Redox Signal 11: 2453-2465, 2009.
88. Fisher AB. Redox signaling across cell membranes. Antioxid Redox Signal 11: 1349-1356, 2009.
89. Fleming PJ and Kent UM. Cytochrome b561, ascorbic acid, and transmembrane electron transfer. Am J Clin Nutr 54: 1173S-1178S, 1991.
90. Fortuño A, Olivan S, Beloqui O, San Jose G, Moreno MU, Diez J, and Zalba G. Association of increased phagocytic NADPH oxidase-dependent superoxide production with diminished nitric oxide generation in essential hyperten-sion. J Hypertens 22: 2169-2175, 2004. (Pubitemid 39463811)
91. Fortuño A, San José G, Moreno MU, Beloqui O, D́ez J, and Zalba G. Phagocytic NADPH oxidase overactivity under-lies oxidative stress in metabolic syndrome. Diabetes 55: 209-215, 2006. (Pubitemid 43343317)
92. Fu X, Beer DG, Behar J, Wands J, Lambeth D, and Cao W. cAMP-response element-binding protein mediates acid-induced NADPH oxidase NOX5-S expression in Barrett esophageal adenocarcinoma cells. J Biol Chem 281: 20368-20382, 2006. (Pubitemid 44065811)
93. Fukui T, Ishizaka N, Rajagopalan S, Laursen JB, Capers Q 4th, Taylor WR, Harrison DG, de Leon H, Wilcox JN, and Griendling KK. p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 80: 45-51, 1997. (Pubitemid 27030367)
94. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, and Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761, 2004. (Pubitemid 40385531)
95. Gaikwad A, Long II DJ, Stringer JL, and Jaiswal AK. In vivo role of NAD(P)H: quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue. J Biol Chem 276: 22559-22564, 2001.
96. Geiszt M and Leto TL. The Nox family of NAD(P)H oxi-dases: host defense and beyond. J Biol Chem 279: 51715-51718, 2004. (Pubitemid 39656535)
97. Geiszt M, Lekstrom K, Witta J, and Leto TL. Proteins ho-mologous to p47phox and p67phox support superoxide production by NAD(P)H oxidase 1 in colon epithelial cells. J Biol Chem 278: 20006-20012, 2003. (Pubitemid 36799193)
98. Ghio AJ, Nozik-Grayck E, Turi J, Jaspers I, Mercatante DR, Kole R, and Piantadosi CA. Superoxide-dependent iron uptake: a new role for anion exchange protein 2. Am J Re-spir Cell Mol Biol 29: 653-660, 2003. (Pubitemid 38045933)
99. Gomez-Diaz C, Rodrguez-Aguilera JC, Barroso MP, Vil-lalba JM, Navarro F, Crane FL, and Navas P. Antioxidant ascorbate is stabilized by NADH-coenzyme Q10 reductase in the plasma membrane. J Bioenerg Biomembr 29: 251-257, 1997. (Pubitemid 27371726)
100. o HL-60 cells by CoQ10 increase at the plasma membrane. Biochem Biophys Res Commun 234: 79-81, 1997.
101. Gonzalez-Gronow M, Kalfa T, Johnson CE, Gawdi G, and Pizzo SV. The voltage-dependent anion channel is a re-ceptor for plasminogen kringle 5 on human endothelial cells. J Biol Chem 278: 27312-27318, 2003. (Pubitemid 36876889)
102. Grebing C, Crane FL, Löw H, and Hall K. A transmem-branous NADH-dehydrogenase in human erythrocyte membranes. J Bioenerg Biomembr 16: 517-533, 1984. (Pubitemid 15174590)
103. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000. (Pubitemid 30165039)
104. Griffiths HR. Is the generation of neo-antigenic determi-nants by free radicals central to the development of auto-immune rheumatoid disease? Autoimmun Rev 7: 544-549, 2008.
105. Guichard C, Moreau R, Pessayre D, Epperson TK, and Krause KH. NOX family NADPH oxidases in liver and in pancreatic islets: a role in the metabolic syndrome and di-abetes? Biochem Soc Trans 36: 920-929, 2008.
106. Gunshin H, Starr CN, Direnzo C, Fleming MD, Jin J, Greer EL, Sellers VM, Galica SM, and Andrews NC. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood 106: 2879-2883, 2005. (Pubitemid 41510768)
107. Hara T and Minakami S. On functional role of cytochrome b5. J Biochem 69: 325-330, 1971.
108. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, and Thannickal VJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15: 1077-1081, 2009.
109. Herst PM and Berridge MV. Cell surface oxygen con-sumption: a major contributor to cellular oxygen con-sumption in glycolytic cancer cell lines. Biochim Biophys Acta 1767: 170-177, 2007. (Pubitemid 46282606)
110. Herst PM and Berridge MV. Plasma membrane electron transport: a new target for cancer drug development. Curr Mol Med 6: 895-904, 2006. (Pubitemid 44883939)
111. Herst PM, Petersen T, Jerram P, Baty J, and Berridge MV. The antiproliferative effects of phenoxodiol are associated with inhibition of plasma membrane electron transport in tumour cell lines and primary immune cells. Biochem Pharmacol 74: 1587-1595, 2007. (Pubitemid 47614971)
112. Herst PM, Tan AS, Scarlett DJ, and Berridge MV. Cell surface oxygen consumption by mitochondrial gene knockout cells. Biochim Biophys Acta 1656: 79-87, 2004. (Pubitemid 38721269)
113. Hicks C and Morré DJ. Oxidation of NADH by intact segments of soybean hypocotyls and stimulation by 2,4-D. Biochim Biophys Acta 1375: 1-5, 1998. (Pubitemid 28511387)
114. Himmelreich U, Drew KN, Serianni AS, and Kuchel PW. 13C NMR studies of vitamin C transport and its redox cycling in human erythrocytes. Biochemistry 37: 7578-7588,1998. (Pubitemid 28235242)
115. Himmelreich U and Kuchel PW. 13C-NMR studies of transmembrane electron transfer to extracellular ferricyanide in human erythrocytes. Eur J Biochem 246: 638-645, 1997. (Pubitemid 27252904)
116. Hohn DC and Lehrer RI. NADPH oxidase deficiency in X-linked chronic granulomatous disease. J Clin Invest 55: 707-713, 1975.
117. Holla IL, Kanková K, and Znojil V. Haplotype analysis of the NADPH oxidase p22 phox gene in patients with bron-chial asthma. Int Arch Allergy Immunol 148: 73-80, 2009.
118. Hosoda S, Nakamura W, and Hayashi K. Properties and reaction mechanism of DT diaphorase from rat liver. J Biol Chem 249: 6416-6423, 1974.
119. Hostetler B, Weston N, Kim C, Morré DM, and Morré DJ. Cancer site-specific isoforms of ENOX2 (tNOX), a cancer-specific cell surface oxidase. Clin Proteom 5: 46-51, 2009.
120. Hotchkiss RS, Strasser A, McDunn JE, and Swanson PE. Cell death. N Engl J Med 361: 1570-1583, 2009.
121. +: an old metabolite controlling new metabolic signaling pathways. Endocr Rev 31: 194-223, 2010.
122. Hsieh TC, Lu X, Wang Z, and Wu JM. Induction of quinone reductase NQO1 by resveratrol in human K562 cells in-volves the antioxidant response element ARE and is ac-companied by nuclear translocation of transcription factor Nrf2. Med Chem 2: 275-285, 2006. (Pubitemid 44083146)
123. Huang J and Brumell JH. NADPH oxidases contribute to autophagy regulation. Autophagy 5: 887-889, 2009.
124. Huang J, Canadien V, Lam GY, Steinberg BE, Dinauer MC, Magalhaes MA, Glogauer M, Grinstein S, and Brumell JH. Activation of antibacterial autophagy by NADPH oxidases. Proc Natl Acad Sci USA; 106: 6226-6631, 2009.
125. Hultquist DE and Passon PG. Catalysis of methaemoglobin reduction by erythrocyte cytochrome B5 and cytochrome B5 reductase. Nat New Biol 229: 252-254, 1971.
126. Hwang JH, Kim DW, Jo EJ, Kim YK, Jo YS, Park JH, Yoo SK, Park MK, Kwak TH, Kho YL, Han J, Choi HS, Lee SH, Kim JM, Lee I, Kyung T, Jang C, Chung J, Kweon GR, and Shong M. Pharmacological stimulation of NADH oxidation ameliorates obesity and related phenotypes in mice. Dia-betes 58: 965-974, 2009.
127. Hyun DH, Emerson SS, Jo DG, Mattson MP, and de Cabo R. Calorie restriction up-regulates the plasma membrane redox system in brain cells and suppresses oxidative stress during aging. Proc Natl Acad Sci USA 103: 19908-19912, 2006. (Pubitemid 46037529)
128. Hyun DH, Hernandez JO, Mattson MP, and de Cabo R The plasma membrane redox system in aging. Ageing Res Rev 5: 209-220, 2006. (Pubitemid 43766257)
129. Jaffè ER and Hsieh HS. DPNH-methemoglobin reductase deficiency and hereditary methemoglobinemia. Semin He-matol 8: 417-437, 1971.
130. Jagnandan D, Church JE, Banfi B, Stuehr DJ, Marrero MB, and Fulton DJ. Novel mechanism of activation of NADPH oxidase 5. Calcium sensitization via phosphorylation. J Biol Chem 282: 6494-6507, 2007. (Pubitemid 47100887)
131. Jaiswal AK. Human NAD(P)H:quinone oxidoreductase (NQO1) gene structure and induction by dioxin. Biochem-istry 30: 10647-10653, 1991.
132. Jana A and Pahan K. Fibrillar amyloid-beta peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase. Implications for Alzheimer's disease. J Biol Chem 279: 51451-51459, 2004. (Pubitemid 40017893)
133. Jiang Z, Gorenstein NM, Morré DM, and Morré DJ. Mole-cular cloning and characterization of a candidate human growth-related and time-keeping constitutive cell surface hydroquinone (NADH) oxidase. Biochemistry 47: 14028-14038, 2008.
134. Jones W, Li X, Qu ZC, Perriott L, Whitesell RR, and May JM. Uptake, recycling, and antioxidant actions of α-lipoic acid in endothelial cells. Free Radic Biol Med 33: 83-93, 2002. (Pubitemid 34681010)
135. Jung J, Hwang SW, Kwak J, Lee SY, Kang CJ, Kim WB, Kim D, and Oh U. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J Neurosci 19: 529-538, 1999. (Pubitemid 29036004)
136. Kagan VE, Arroyo A, Tyurin VA, Tyurina YY, Villalba JM, and Navas P. Plasma membrane NADH-coenzyme Q0 re-ductase generates semiquinone radicals and recycles vita-min E homologue in a superoxide-dependent reaction. FEBS Lett 428: 43-46, 1998. (Pubitemid 28266824)
137. Kamata T. Roles of Nox1 and other Nox isoforms in cancer development. Cancer Sci 100: 1382-1388, 2009.
138. Karplus PA, Daniels MJ, and Herriott JR. Atomic structure of ferredoxin-NADP+reductase: prototype for a structur-ally novel flavoenzyme family. Science 251: 60-66, 1991. (Pubitemid 21916851)
139. Kawahara T, Teshima S, Oka A, Sugiyama T, Kishi K, and Rokutan K. Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells. Infect Immun 69: 4382-4389, 2001. (Pubitemid 32574436)
140. Kelker M, Kim C, Chueh P-J, Guimont R, Morré DM, and Morré DJ. Cancer isoform of a tumor-associated cell sur-faceNADHoxidase (tNOX) has properties of a prion. Bio-chemistry 40: 7351-7354, 2001. (Pubitemid 32578000)
141. Kennett EC and Kuchel PW. Plasma membrane oxidore-ductases: effects on erythrocyte metabolism and redox ho-meostasis. Antioxid Redox Signal 8: 1241-1247, 2006. (Pubitemid 44182422)
142. Kennett EC and Kuchel PW. Redox reactions and electron transfer across the red cell membrane. IUBMB Life 55: 375-385, 2003. (Pubitemid 37271095)
143. Kennett EC, Ogawa E, Agar NS, Godwin IR, Bubb WA, and Kuchel PW. Investigation of methaemoglobin reduc-tion by extracellular NADH in mammalian erythrocytes. Int J Biochem Cell Biol 37: 1438-1445, 2005.
144. Kern DG, Draelos ZD, Meadows C, Morré DJ, and Morré DM. Controlling reactive oxygen species in skin at their source to reduce skin aging. Rejuvenation Res 13: 1-3, 2010.
145. Keyes SR and Cinti DL. Biochemical properties of cyto-chrome c-dependent microsomal fatty acid elongation and identification of products. J Biol Chem 255:11357-11364,1980. (Pubitemid 11134247)
146. Kikuchi H, Hikage M, Miyashita H, and Fukumoto M. NADPH oxidase subunit, gp91(phox) homologue, prefer-entially expressed in human colon epithelial cells. Gene 254: 237-243, 2000.
147. Kilberg MS and Christensen HN Electron-transferring en-zymes in the plasma membrane of the Ehrlich ascites tumor cell. Biochemistry 18: 1525-1530, 1979.
148. Kim C, MacKellar WC, Cho N Byrn SR, and Morré DJ. Impermeant antitumor sulfonylurea conjugates that in-hibit plasma membrane NADH oxidase and growth of HeLa cells in culture. Identification of binding proteins from sera of cancer patients. Biochim Biophys Acta 1324: 171-181, 1997. (Pubitemid 27117824)
149. Kim JS, Diebold BA, Babior BM, Knaus UG, and Bokoch GM. Regulation of Nox1 activity via protein kinase A-me-diated phosphorylation of NoxA1 and 14-3-3 binding. J Biol Chem 282: 34787-34800, 2007. (Pubitemid 350232473)
150. Kimura S, Kawamura M, and Iyanagi T. Role of Thr(66) in porcine NADH-cytochrome b5 reductase in catalysis and control of the rate-limiting step in electron transfer. J Biol Chem 278: 3580-2589, 2003.
151. Kinnula VL. Production and degradation of oxygen me-tabolites during inflammatory states in the human lung. Curr Drug Targets Inflamm Allergy 2: 465-470, 2005. (Pubitemid 41052411)
152. Kishi T, Morré DM, and Morré DJ. The plasma membrane NADH oxidase of HeLa cells has hydroquinone oxidase activity. Biochim Biophys Acta 1412: 66-77, 1999. (Pubitemid 29238118)
153. Kishida KT, Hoeffer CA, Hu D, Pao M, Holland SM, and Klann E. Synaptic plasticity deficits and mild memory im-pairments in mouse models of chronic granulomatous disease. Mol Cell Biol 26: 5908-5920, 2006. (Pubitemid 44134344)
154. Krauskopf A, Eriksson O, CraigenWJ, Forte MA, and Bernardi P. Properties of the permeability transition in VDAC1(\/\) mitochondria. Biochim Biophys Acta 1757: 590-595, 2006. (Pubitemid 43993836)
155. Kurian JR, Bajad SU, Miller JL, Chin NA, and Trepanier LA. NADH cytochrome b5 reductase and cytochrome b5 cata-lyze the microsomal reduction of xenobiotic hydroxyl-amines and amidoximes in humans. J Pharmacol Exp Ther 311: 1171-1178, 2004. (Pubitemid 39612725)
156. Kurokawa M and Kornbluth S. Caspases and kinases in a death grip. Cell 138: 838-854, 2009.
157. Lane DJ and Lawen A. Ascorbate and plasma membrane electron transport\enzymes vs efflux. Free Radic Biol Med 47: 485-495, 2009.
158. Lane DJ and Lawen A. Transplasma membrane electron transport comes in two flavors. Biofactors 34: 191-200, 2009.
159. + exchangers and intracellular pH in regulating vitamin C-driven electron transport across the plasma membrane. Biochem J 428: 191-200, 2010.
160. Lane DJR and Lawen A. Non-transferrin iron reduction and uptake are regulated by transmembrane ascorbate cycling in K562 cells. J Biol Chem 283: 12701-12708, 2008.
161. Larm JA, Vaillant F, Linnane AW, and Lawen A. Up-regulation of the plasma membrane oxidoreductase as a prerequisite for the viability of human Namalwa rho 0 cells. J Biol Chem 269: 30097-30100, 1994. (Pubitemid 24376469)
162. Lass A, Forster MJ, and Sohal RS. Effects of coenzyme Q10 and alphatocopherol administration on their tissue levels in the mouse: elevation of mitochondrial alpha-tocopherol by coenzyme Q10. Free Radical Biol Med 26: 1375-1382, 1999. (Pubitemid 29302269)
163. Laurent E, McCoy JW 3rd, Macina RA, Liu W, Cheng G, Robine S, Papkoff J, and Lambeth JD. Nox1 is over-expressed in human colon cancers and correlates with activating mutations in K-Ras. Int J Cancer 123: 100-107, 2008. (Pubitemid 351705197)
164. Lawen A, Ly JD, Lane DJ, Zarschler K, Messina A, and De Pinto V. Voltage-dependent anion-selective channel 1 (VDAC1)\a mitochondrial protein, rediscovered as a no-vel enzyme in the plasma membrane. Int J Biochem Cell Biol 37: 277-282, 2005. (Pubitemid 39330189)
165. Lee MY, San Martin A, Mehta PK, Dikalova AE, Garrido AM, Datla SR, Lyons E, Krause KH, Banfi B, Lambeth JD, Lassègue B, and Griendling KK. Mechanisms of vascular smooth muscle NADPH oxidase 1 (Nox1) contribution to injury-induced neointimal formation. Arterioscler Thromb Vasc Biol 29: 480-487, 2009.
166. Lee S, Li R, Kim B, Palvolgyi R, Ho T, Yang Q-Z, Xu J, Szeto WL, Honda H, and Berliner JA. Ox-PAPC activation of PMET system increases expression of heme oxygenase-1 in human aortic endothelial cell. J Lipid Res 50: 265-274, 2009.
167. Lee YM, Kim BJ, Chun YS, So I, Choi H, Kim MS, and Park JW. NOX4 as an oxygen sensor to regulate TASK-1 activity. Cell Signal 18: 499-507, 2006. (Pubitemid 41790370)
168. Lenaz G, Paolucci U, Fato R, D'Aurelio M, Parenti Castelli G, Sgarbi G, Biagini G, Ragni L, Salardi S, and Cacciari E. Enhanced activity of the plasma membrane oxidoreductase in circulating lymphocytes from insulin-dependent diabe-tes mellitus patients. Biochem Biophys Res Commun 290: 1589-1592, 2002. (Pubitemid 34687440)
169. Lewis IA, Campanella ME, Markley JL, and Low PS. Role of band 3 in regulating metabolic flux of red blood cells. Proc Natl Acad Sci USA 106: 18515-18520, 2009.
170. Li R, Bianchet MA, Talalay P, and Amzel LM. The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and che-motherapy: mechanism of the two-electron reduction. Proc Natl Acad Sci USA 92: 8846-8850, 1995.
171. Lin SJ and Guarente L. Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and dis-ease. Curr Opin Cell Biol 15: 241-246, 2003. (Pubitemid 36332200)
172. Lind C, Cadenas E, Hochstein P, and Ernster L. DT-diaphorase: purification, properties and function. Methods Enzymol 186: 287-301, 1990.
173. Liu SC, Yang JJ, Shao KN, and Chueh PJ. RNA interference targeting tNOX attenuates cell migration via a mechanism that involves membrane association of Rac. Biochem Biophys Res Commun 365: 672-677, 2008. (Pubitemid 350234843)
174. Lopez-Lluch G, Rios M, Lane MA, Navas P, and de Cabo R Mouse liver plasma membrana redox system activity is altered by aging and modulated by calorie restriction. AGE 27: 153-160, 2005. (Pubitemid 43978799)
175. Ludwiczek S, Rosell FI, Ludwiczek ML, and Mauk AG Recombinant expression and initial characterization of the putative human enteric ferric reductase Dcytb. Biochemistry 47: 753-761, 2008. (Pubitemid 351195446)
176. Luxen S, Belinsky SA, and Knaus UG. Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. Cancer Res 68: 1037-1045, 2008. (Pubitemid 351272221)
177. Ly JD and Lawen A. Transplasma membrane electron transport: enzymes involved and biological function. Redox Rep 8: 3-21, 2003. (Pubitemid 36204248)
178. Macho A, Calzado MA, Munoz-Blanco J, Gomez-Diaz C, Gajate C, Mollinedo F, Navas P, and Muñoz E. Selective induction of apoptosis by capsaicin in transformed cells: the role of reactive oxygen species and calcium. Cell Death Differ 6: 155-165, 1999. (Pubitemid 29082304)
179. Macho A, Lucena C, Calzado MA, Blanco M, Donnay I, Appendino G, and Muñoz E. Phorboid 20-homovanillates induce apoptosis through a VR1-independent mechanism. Chem Biol 7: 483-492, 2000. (Pubitemid 30466983)
180. Madesh M and Hajnoczky G. VDAC-dependent permea-bilization of the outer mitochondrial membrane by super-oxide induces rapid and massive cytochrome c release. J Cell Biol 155: 1003-1016, 2001.
181. Mangiullo R, Gnoni A, Leone A, Gnoni GV, Papa S, and Zanotti F. Structural and functional characterization of F(o)F(1)-ATP synthase on the extracellular surface of rat hepatocytes. Biochim Biophys Acta 1777: 1326-1335, 2008.
182. Margutti P, Matarrese P, Conti F, Colasanti T, Delunardo F, Capozzi A, Garofalo T, Profumo E, Riganò R, Siracusano A, Alessandri C, Salvati B, Valesini G, Malorni W, Sorice M, and Ortona E. Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and endothelial cell apo-ptosis in immune-mediated vascular diseases and athero-sclerosis. Blood 111: 4559-4570, 2008.
183. Marques F, Crespo ME, and Bicho M. Control of NADH ferricyanide reductase activity in the human erythrocyte by somatotrophin and insulin. Redox Rep 1: 113-117, 1995.
184. Mart́n SF, Gómez-D́az C, Bello RI, Navas P, and Villalba JM. Inhibition of neutral Mg2+-dependent sphingomyeli-nase by ubiquinol-mediated plasma membrane electron transport. Protoplasma 221: 109-116, 2003. (Pubitemid 36658590)
185. Mart́n SF, Navarro F, Forthoffer N, Navas P, and Villalba JM. Neutral magnesium-dependent sphingomyelinase from liver plasma membrane: purification and inhibition by ubiquinol. J Bioenerg Biomembr 33: 143-153, 2001. (Pubitemid 32466390)
186. Mart́n-Romero FJ, Garća-Mart́n E, and Gutiérrez-Merino C. Inhibition of oxidative stress produced by plasma membrane NADH oxidase delays low-potassium-induced apoptosis of cerebellar granule cells. J Neurochem 82: 705-715, 2002. (Pubitemid 34831508)
187. Martn-Romero FJ, Gutierrez-Martn Y, Henao F, and Gutierrez-Merino C. the NADH oxidase activity of the plasma membrane of synaptosomes is a major source of superoxide anion and is inhibited by peroxynitrite. J Neurochem 82: 604-614, 2002
188. Mathupala SP and Pedersen, PL. Voltage dependent anion channel-1 (VDAC-1) as an anti-cancer target. Cancer Biol Ther 9: 1053-1056, 2010.
189. Matsushita H, Lee K, and Tsao PS. Cyclic strain induces reactive oxygen species production via an endothelial NAD(P)H oxidase. J Cell Biochem 81: 99-106, 2001.
190. Matteucci E, Cupisti A, Caprioli R, Battipaglia E, Favilla S, Rindi P, Barsotti G, and Giampietro O. Erythrocyte trans-membrane electron transfer in haemodialysis patients. Nutr Metab Cardiovasc Dis 17: 288-293, 2007. (Pubitemid 46551683)
191. May JM, Qu Z-C, and Mendiratta S. Protection and re-cycling of a-tocopherol in human erythrocytes by intracel-lular ascorbic acid. Arch Biochem Biophys 349: 281-289,1998. (Pubitemid 28368672)
192. May JM, Qu ZC, and Nelson DJ. Uptake and reduction of α-lipoic acid by human erythrocytes. Clin Biochem 40: 1135-1142, 2007. (Pubitemid 47379324)
193. May JM, Qu Z-C, and Whitesell RR. Ascorbic acid recycling enhances the antioxidant reserve of human erythrocytes. Biochemistry 34: 12721-12728, 1995.
194. May JM. Is ascorbic acid an antioxidant for the plasma membrane? FASEB J 13: 995-1006, 1999.
195. McIntyre JA, Wagenknecht DR, and Faulk WP. Auto-antibodies unmasked by redox reactions. J Autoimmun 24: 311-317, 2005.
196. McKie AT, Barrow D, Latunde-Dada GO, Rolfs A, Sager G, Mudaly E, Mudaly M, Richardson C, Barlow D, Bomford A, Peters TJ, Raja KB, Shirali S, Hediger MA, Farzaneh F, and Simpson RJ. An iron-regulated ferric reductase asso-ciated with the absorption of dietary iron. Science 291: 1755-1759, 2001. (Pubitemid 32198974)
197. McKie AT. The role of Dcytb in iron metabolism: an up-date. Biochem Soc Trans 36: 1239-1241, 2008.
198. Messana I, Orlando M, Cassiano L, Pennacchietti L, Zuppi C, Castagnola M, and Giardina B. Human erythrocyte metabolism is modulated by the O2-linked transition of hemoglobin. FEBS Lett 390: 25-28, 1996. (Pubitemid 26233260)
199. Mitsushita J, Lambeth JD, and Kamata T. The superoxide-generating oxidase Nox1 is functionally required for Ras oncogene transformation. Cancer Res 64: 3580-3585, 2004. (Pubitemid 38657935)
200. Mizushima N, Levine B, Cuervo AM, and Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 451: 1069-1075, 2008. (Pubitemid 351317450)
201. Mochizuki T, Furuta S, Mitsushita J, Shang WH, Ito M, Yokoo Y, Yamaura M, Ishizone S, Nakayama J, Konagai A, Hirose K, Kiyosawa K, and Kamata T. Inhibition of NADPH oxidase 4 activates apoptosis via the AKT/apoptosis signal-regulating kinase 1 pathway in pancreatic cancer PANC-1 cells. Oncogene 25: 3699-3707, 2006. (Pubitemid 43980491)
202. Moreno JC, Bikker H, Kempers MJ, van Trotsenburg AS, Baas F, de Vijlder JJ, Vulsma T, and Ris-Stalpers C. In-activating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism. N Engl J Med 347: 95-102, 2002. (Pubitemid 34753479)
203. Morré DJ and Brightman AO. NADH oxidase of plasma membranes. J Bioenerg Biomem 23: 469-489, 1991.
204. Morré DJ and Morré DM. Aging-related cell surface ECTO-NOX protein, arNOX, a preventive target to reduce ath-erogenic risk in the elderly. Rejuvenation Res 9: 231-236,2006. (Pubitemid 43856815)
205. Morré DJ and Morré DM. Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular time-keeping, growth, aging and neurodegenerative diseases. Free Radic Res 37: 795-808, 2003. (Pubitemid 36939596)
206. Morré DJ, Chueh P-J, Lawler J, and Morré DM. The sulfo-nylurea-inhibited NADH oxidase activity of HeLa cell plasma membranes has properties of a protein disulfide-thiol oxidoreductase with protein disulfide-thiol inter-change activity. J Bioenerg Biomembr 30: 477-487, 1998. (Pubitemid 29051599)
207. Morré DJ, Chueh P-J, Pletcher J, Tang X, Wu L-Y, and Morré DM. Biochemical basis for the biological clock. Bio-chemistry 41: 11941-11945, 2002.
208. Morré DJ, Hostetler B, Weston N, Kim C, and Morré DM. Cancer type-specific tNOX isoforms: a putative family of redox protein splice variants with cancer diagnostic and prognostic potential. Biofactors 34: 201-207, 2009.
209. Morré DJ, Orczyk J, Hignite H, and Kim C. Regular oscillatory behavior of aqueous solutions of CuII salts re-lated to effects on equilibrium dynamics of ortho/para hydrogen spin isomers of water. J Inorg Biochem 102: 260-267, 2008.
210. Morré DJ, Sun E, Geilen C, Wu L-Y, de Cabo R, Krasagakis K, Orfanos CE, and Morré DM. Capsaicin inhibits plasma membrane NADH oxidase and growth of human and mouse melanoma lines. Eur J Cancer 32: 1995-2003, 1996. (Pubitemid 26361697)
211. Morré DJ. NADH oxidase activity of HeLa plasma membranes inhibited by the antitumor sulfonylurea N-(4-methylphenylsulfonyl)-N0-(4-chlorophenyl) urea (LY181984) at an external site. Biochim Biophys Acta 1240: 201-208,1995. (Pubitemid 26005548)
212. Morré DM and Morré DJ. Specificity of coenzyme Q inhi-bition of an aging-related cell surface NADH oxidase (ECTO-NOX) that generates superoxide. Biofactors 18: 33-43, 2003. (Pubitemid 38030698)
213. Morré DM, Guo F, and Morré DJ. An aging-related cell surface NADH oxidase (arNOX) generates superoxide and is inhibited by coenzyme Q. Mol Cell Biochem 254: 101-109, 2003. (Pubitemid 37483744)
214. Morré DM, Morré DJ, Rehmus W, and Kern D. Supple-mentation with CoQ10 lowers age-related (ar) NOX levels in healthy subjects. Biofactors 32: 221-230, 2008.
215. Nauseef WM. Biological roles for the NOX family NADPH oxidases. J Biol Chem 283: 16961-16965, 2008.
216. Navarro F, Navas P, Burgess JR, Bello RI, De Cabo R, Arroyo A, and Villalba JM. Vitamin E and selenium defi-ciency induces expression of the ubiquinone-dependent antioxidant system at the plasma membrane. FASEB J 12: 1665-1673, 1998. (Pubitemid 28553661)
217. Navas P, Villalba JM, and de Cabo R. The importance of plasma membrane coenzyme Q in aging and stress re-sponses. Mitochondrion 7: S34-S40, 2007. (Pubitemid 46722290)
218. Nishida H, Inaka K, Yamanaka M, Kaida S, Kobayashi K, and Miki K. Crystal structure of NADH-cytochrome b5 reductase from pig liver at 2.4 A resolution. Biochemistry 34: 2763-2767, 1995.
219. Nolan KA, Doncaster JR, Dunstan MS, Scott KA, Frenkel AD, Siegel D, Ross D, Barnes J, Levy C, Leys D, Whitehead RC, Stratford IJ, and Bryce RA. Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1). J Med Chem 52: 7142-7156, 2009.
220. Nozik-Grayck E, Piantadosi CA, van Adelsberg J, Alper SL, and Huang YCT. Protection of perfused lung from oxidant injury by inhibitors of anion exchange. Am J Physiol Lung Cell Mol Physiol 273: L296-L304, 1997.
221. Nutter LM, Ngo EO, Fisher GR, and Gutierrez PL. DNA strand scission and free radical production in menadione-treated cells. Correlation with cytotoxicity and role of NADPH quinone acceptor oxidoreductase. J Biol Chem 267: 2474-2479, 1992.
222. Oakhill JS, Marritt SJ, Gareta EG, Cammack R, and McKie AT. Functional characterization of human duodenal cyto-chrome b (Cybrd1): redox properties in relation to iron and ascorbate metabolism. Biochim Biophys Acta 1777: 260-268, 2008.
223. Okun JG, Lummen P, and Brandt U. Three classes of in-hibitors share a common binding domain in mitochondrial complex I (NADH:ubiquinone oxidoreductase). J Biol Chem 274: 2625-2630, 1999. (Pubitemid 29075339)
224. Orringer EP and Roer ME. An ascorbate-mediated trans-membrane-reducing system of the human erythrocyte. J Clin Invest 63: 53-58, 1979. (Pubitemid 9085079)
225. 5 in fatty acid desaturation by rat liver microsomes. J Biochem (Tokyo) 69: 155-167, 1971.
226. Ozols J, Carr SA, and Strittmatter P. Identification of the NH2-terminal blocking group of NADH-cytochrome b5 reductase as myristic acid and the complete amino acid sequence of the membrane-binding domain. J Biol Chem 259: 13349-13354, 1984. (Pubitemid 15223865)
227. Pachucki J, Wang D, Christophe D, and Miot F. Structural and functional characterization of the two human ThOX/Duox genes and their 5'-flanking regions. Mol Cell Endocrinol 214: 53-62, 2004. (Pubitemid 38210115)
228. Paffenholz R, Bergstrom RA, Pasutto F, Wabnitz P, Munroe RJ, Jagla W, Heinzmann U, Marquardt A, Bareiss A, Laufs J, Russ A, Stumm G, Schimenti JC, and Bergstrom DE. Vestibular defects in head-tilt mice result from mutations in Nox3, encoding an NADPH oxidase. Genes Dev 18: 486-491, 2004. (Pubitemid 38372805)
229. Palming J, Sjoholm K, Jernas M, Lystig TC, Gummesson A, Romeo S, Lonn L, Lonn M, Carlsson B, and Carlsson LM. The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction. J Clin Endocrinol Metab 92: 2346-2352, 2007. (Pubitemid 46997144)
230. Pao M, Wiggs EA, Anastacio MM, Hyun J, DeCarlo ES, Miller JT, Anderson VL, Malech HL, Gallin JI, and Holland. SM. Cognitive function in patients with chronic granulo-matous disease: a preliminary report. Psychosomatics 45: 230-234, 2004. (Pubitemid 38621532)
231. Park L, Zhou P, Pitstick R, Capone C, Anrather J, Norris EH, Younkin L, Younkin S, Carlson G, McEwen BS, and Iadecola C. Nox2-derived radicals contribute to neurovas-cular and behavioral dysfunction in mice overexpressing the amyloid precursor protein. Proc Natl Acad SciUSA 105: 1347-1352, 2008. (Pubitemid 351397056)
232. Parkos CA, Allen RA, Cochrane CG, and Jesaitis AJ. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides with relative molecular weights of 91,000 and 22,000. J Clin Invest 80: 732-742,1987. (Pubitemid 18003944)
233. Passon PG and Hultquist DE. Soluble cytochrome b 5 re-ductase from human erythrocytes. Biochim Biophys Acta 275: 62-73, 1972.
234. Pelicano H, Xu R, Du M, Feng L, Sasaki R, Carew JS, Hu Y, Ramdas L, Hu L, Keating MJ, Zhang W, Plunkett W, and Huang P. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox mediated mechanism. J Cell Biol 175: 913-923, 2006. (Pubitemid 44969197)
235. Percy MJ and Lappin TR. Recessive congenital methae-moglobinaemia: cytochrome b(5) reductase deficiency. Br J Haematol 141: 298-308, 2008. (Pubitemid 351521146)
236. Pignatelli P, Sanguigni V, Paola SG, Lo Coco E, Lenti L, and Violi F. Vitamin C inhibits platelet expression of CD40 li-gand. Free Radic Biol Med 38: 1662-1666, 2005. (Pubitemid 40726072)
237. Pink JJ, Planchon SM, Tagliarino C, Varnes ME, Siegel D, and Boothman DA. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cy-totoxicity. J Biol Chem 275: 5416-5424, 2000. (Pubitemid 30115173)
238. Prata C, Grasso C, Loizzo S, Sega FV, Caliceti C, Zambonin L, Fiorentini D, Hakim G, Berridge MV, and Landi L. In-hibition of trans-plasma membrane electron transport: a potential anti-leukemic strategy. Leuk Res doi:10.1016/j.leukres.2010.02.032, 2010.
239. Prata C, Maraldi T, Fiorentini D, Zambonin L, Hakim G, and Landi L. Nox-generated ROS modulate glucose uptake in a leukaemic cell line. Free Radic Res 42: 405-414, 2008. (Pubitemid 351935154)
240. Raghu G, Weycker D, Edelsberg J, Bradford WZ, and Oster G. Incidence and prevalence of idiopathic pulmonary fi-brosis. Am J Respir Crit Care Med 174: 810-816, 2006. (Pubitemid 44511663)
241. Reddy VV, Kupfer D, and Capsi E. Mechanism of C-5 double bond introduction in the biosynthesis of choles-terol by rat liver microsomes. J Biol Chem 252: 2797-2801, 1977.
242. Rivlin J, Mendel J, Rubinstein S, Etkovitz N, and Breitbart H. Role of hydrogen peroxide in sperm capacitation and acrosome reaction. Biol Reprod 70: 518-522, 2004. (Pubitemid 38160116)
243. Rizvi SI, Jha R, and Maurya PK. Erythrocyte plasma membrane redox system in human aging. Rejuvenation Res 9: 470-474, 2006. (Pubitemid 46100668)
244. Rodŕguez-Alonso J, Montañez R, Rodŕguez-Caso L, and Medina MA. Homocysteine is a potent modulator of plas-ma membrane electron transport systems. J Bioenerg Bio-membr 40: 45-51, 2008.
245. Rogers SC, Said A, Corcuera D, McLaughlin D, Kell P, and Doctor A. Hypoxia limits antioxidant capacity in red blood cells by altering glycolytic pathway dominance. FASEB J 23: 3159-3170, 2009.
246. Rossi F and Zatti M. Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxi-dation by the granules of resting and phagocytizing cells. Experientia 20: 21-23, 1964.
247. Rubinstein B and Luster DG. Plasma membrane redox ac-tivity: components and role in plant processes. Ann Rev Plant Physiol Plant Mol Biol 44: 131-155, 1993.
248. Sabeur K and Ball BA. Characterization of NADPH oxidase 5 in equine testis and spermatozoa. Reproduction 134: 263-267, 2007.
249. Sakagami H, Satoh K, Ohata H, Takahashi H, Yoshida H, Iida M, Kuribayashy N, Sakagamy T, Momose K, and Ta-keda M. Relationship between ascorbyl radical intensity and apoptosis-inducing activity. Anticancer Res 16: 2981-2986, 1996. (Pubitemid 26388282)
250. Samhan-Arias AK, Duarte RO, Mart́n-Romero FJ, Moura JJ, and Gutiérrez-Merino C. Reduction of ascorbate free radical by the plasma membrane of synaptic terminals from rat brain. Arch Biochem Biophys 469: 243-254, 2008. (Pubitemid 350298108)
251. Samhan-Arias AK, Garcia-Bereguiain MA, Martin-Romero FJ, and Gutierrez-Merino C. Clustering of plasma mem-brane-bound cytochrome b5 reductase within "lipid raft" microdomains of the neuronal plasma membrane. Mol Cell Neurosci 40: 14-26, 2009.
252. Sánchez AM, Malagarie-Cazenave S, Olea N, Vara D, Chiloeches A, and D́az-Laviada I. Apoptosis induced by capsaicin in prostate PC-3 cells involves ceramide accu-mulation, neutral sphingomyelinase, and JNK activation. Apoptosis 12: 2013-2024, 2007. (Pubitemid 47498227)
253. Savini I, Arnone R, Rossi A, Catani MV, Del Principe D, and Avigliano L. Redox modulation of Ecto-NOX1 in human platelets. Mol Membr Biol 27: 160-169, 2010.
254. Savini I, Catani MV, Arnone R, Rossi A, Frega G, Del Principe D, and Avigliano L. Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic Biol Med 42: 608-616, 2007. (Pubitemid 46205144)
255. Scarlett DJ, Herst P, Tan A, Prata C, and Berridge M. Mi-tochondrial gene-knockout (rho0) cells: a versatile model for exploring the secrets of trans-plasma membrane elec-tron transport. Biofactors 20: 199-206, 2004.
256. Scarlett DJ, Herst PM, and Berridge MV. Multiple proteins with single activities or a single protein with multiple ac-tivities: the conundrum of cell surface NADH oxidore-ductases. Biochim Biophys Acta 1708: 108-119, 2005. (Pubitemid 40798535)
257. Scholz RW, Minicucci LA, and Reddy CC. Effects of vita-min E and selenium on antioxidant defense in rat heart. Biochem. Mol Biol Int 42: 997-1006, 1997. (Pubitemid 28297592)
258. Schröder K, Helmcke I, Palfi K, Krause KH, Busse R, and Brandes RP. Nox1 mediates basic fibroblast growth factor-induced migration of vascular smooth muscle cells. Arter-ioscler Thromb Vasc Biol 27: 1736-1743, 2007. (Pubitemid 47207168)
259. Schulze U, Schott H, and Staudinger H. Isolierung und charakterisierung einer NADH:semidehydroascorbinsaure-oxidoreduktase aus Neurospora crassa. Hoppe-Seyler's Z Physiol Chem 353: 1931-1942, 1972.
260. Scott EM and Griffith IV The enzymic defect of hereditary methemoglobinemia: diaphorase. Biochim Biophys Acta 34: 584-586, 1959.
261. Seigel D, Gustafson DL, Dehn DL, Han JY, Boonchoong P, Berliner LJ, and Ross D. NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger. Mol Pharmacol 65: 1238-1247, 2004. (Pubitemid 38543494)
262. Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29: 625-634, 2010.
263. Semenza GL. Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 19: 12-16,2009.
264. Seno T, Inoue N, Gao D, Okuda M, Sumi Y, Matsui K, Yamada S, Hirata KI, Kawashima S, Tawa R, Imajoh-Ohmi S, Sakurai H, and Yokoyama M. Involvement of NADH/NADPH oxidase in human platelet ROS produc-tion. Thromb Res 103: 399-409, 2001. (Pubitemid 32831474)
265. Serrander L, Cartier L, Bedard K, Banfi B, Lardy B, Plastre O, Sienkiewicz A, Fórró L, Schlegel W, and Krause KH. NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation. Biochem J 406: 105-114, 2007. (Pubitemid 47264740)
266. Shimizu S, Matsuoka Y, Shinohara Y, Yoneda Y, and Tsu-jimoto Y. Essential role of voltage-dependent anion channel in various forms of apoptosis in mammalian cells. J Cell Biol 152: 237-250, 2001. (Pubitemid 34285595)
267. Shimizu S, Narita M, and Tsujimoto Y. BcL-2 family pro-teins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC Nature 399: 483-487, 1999. (Pubitemid 29258855)
268. Shinohara M, Shang WH, Kubodera M, Harada S, Mit-sushita J, Kato M, Miyazaki H, Sumimoto H, and Kamata T. Nox1 redox signaling mediates oncogenic Ras-induced disruption of stress fibers and focal adhesions by down-regulating Rho. J Biol Chem 282: 17640-17648, 2007. (Pubitemid 47100324)
269. Shiose A, Kuroda J, Tsuruya K, Hirai M, Hirakata H, Naito S, Hattori M, Sakaki Y, and Sumimoto H. A novel super-oxide-producing NAD(P)H oxidase in kidney. J Biol Chem 276: 1417-1423, 2001. (Pubitemid 32096573)
270. Shirabe K, Landi MT, Takeshita M, Uziel G, Fedrizzi E, and Borgese N. A novel point mutation in a 3' splice site of the NADH-cytochrome b5 reductase gene results in immuno-logically undetectable enzyme and impaired NADH-dependent ascorbate regeneration in cultured fibroblasts of a patient with type II hereditary methemoglobinemia. Am J Hum Genet 57: 302-310, 1995.
271. Shukla S, Jha RK, Laloraya M, and Kumar PG. Identification of nonmitochondrial NADPH oxidase and the spatio-temporal organization of its components in mouse sperma-tozoa. Biochem Biophys Res Commun 331: 476-483, 2005. (Pubitemid 40602662)
272. Song Y, Ruf J, Lothaire P, Dequanter D, Andry G, Willemse E, Dumont JE, Van Sande J, and De Deken X. Association of duoxes with thyroid peroxidase and its regulation in thyrocytes. J Clin Endocrinol Metab 95: 375-382, 2010.
273. Stasia MJ and Li XJ. Genetics and immunopathology of chronic granulomatous disease. Semin Immunopathol 30: 209-235, 2008.
274. Strittmatter P. The reaction sequence in electron transfer in the reduced nicotinamide adenine dinucleotide-cytochrome b5 reductase system. J Biol Chem 240: 4481-4487,1965.
275. Su D and Asard H. Three mammalian cytochromes b561 are ascorbate-dependent ferrireductases. FEBS J 273: 3722-3734, 2006. (Pubitemid 44166653)
276. Su D, May JM, Koury MJ, and Asard H. Human erythro-cyte membranes contain a cytochrome b561 that may be involved in extracellular ascorbate recycling. J Biol Chem 281: 39852-39859, 2006. (Pubitemid 46041788)
277. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD. Cell trans-formation by the superoxide-generating oxidase Mox1. Nature 401: 79-82, 1999.
278. Sumimoto H, Hata K, Mizuki K, Ito T, Kage Y, Sakaki Y, Fukumaki Y, Nakamura M, and Takeshige K. Assembly and activation of the phagocyte NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of p47phox with p22phox is required for activation of the NADPH oxidase. J Biol Chem 271: 22152-22158, 1996. (Pubitemid 26303847)
279. Sumimoto H. Structure, regulation and evolution of Nox-family NADPH oxidases that produce reactive oxygen species. FEBS J 275: 3249-3277, 2008. (Pubitemid 351813551)
280. Tabet F, Schiffrin EL, Callera GE, He Y, Yao G, Ostman A, Kappert K, Tonks NK, and Touyz RM. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phos-phatase SHP-2 in vascular smooth muscle cells from SHR. Circ Res 103: 149-158, 2008.
281. Tan AS and Berridge MV. Superoxide produced by acti-vated neutrophils efficiently reduces the tetrazolium salt WST-1 to produce a soluble formazan: a simple colori-metric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J Immunol Methods 238: 59-68, 2000. (Pubitemid 30175986)
282. Tan AS and Berridge MV. Distinct trans-plasma membrane redox pathways reduce cell-impermeable dyes in HeLa cells. Redox Rep 9: 302-306, 2004. (Pubitemid 40185432)
283. Tan AS and Berridge MV. Differential effects of redox-cy-cling and arylating quinones on trans-plasma membrane electron transport. Biofactors 34: 183-190, 2009.
284. Tan AS and Berridge MV. Evidence for NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated quinone-dependent redox cycling via plasma membrane electron transport: A sensitive cellular assay for NQO1. Free Radic Biol Med 48: 421-429, 2010.
285. Thinnes FP. Evidence for extra-mitochondrial localization of the VDAC/porin channel in eucaryotic cells. J Bioenerg Biomembr 24: 71-75, 1992.
286. Tirone F and Cox JA. NADPH oxidase 5 (NOX5) interacts with and is regulated by calmodulin. FEBS Lett 581: 1202-1208, 2007. (Pubitemid 46385949)
287. Tomatsu S, Kobayashi Y, Fukumaki Y, Yubisui T, Orii T, and Sakaki Y. The organization and the complete nucleo-tide sequence of the human NADH-cytochrome b5 reduc-tase gene. Gene 80: 353-361, 1989. (Pubitemid 19226588)
288. Tominaga K, Kawahara T, Sano T, Toida K, Kuwano Y, Sasaki H, Kawai T, Teshima-Kondo S, and Rokutan K. Evidence for cancer-associated expression of NADPH oxi-dase 1 (Nox1)-based oxidase system in the human stomach Free Radic Biol Med 43: 1627-1638, 2007. (Pubitemid 350122987)
289. Touyz RM and Schiffrin EL. Increased generation of su-peroxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phos-pholipase D-dependent NAD(P)H oxidase-sensitive path-ways. J Hypertens 19: 1245-1254, 2001. (Pubitemid 32595280)
290. Tran UC and Clarke CF. Endogenous synthesis of coen-zyme Q in eukaryotes. Mitochondrion 7: S62-S71, 2007.
291. Tsujimoto Y and Shimizu S. Role of the mitochondrial membrane permeability transition in cell death. Apoptosis 12: 835-840, 2007. (Pubitemid 46653286)
292. Tsunawaki S, Kagara S, Yoshikawa K, Yoshida LS, Kur-atsuji T, and Namiki H. Involvement of p40phox in acti-vation of phagocyte NADPH oxidase through association of its carboxyl-terminal, but not its amino-terminal, with p67phox. J Exp Med 184: 893-902, 1996.
293. Turi JL, Wang X, McKie AT, Nozik-Grayck E, Mamo LB, Crissman K, Piantadosi CA, and Ghio AJ. Duodenal cyto-chrome b: a novel ferrireductase in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 291: L272-L280, 2006. (Pubitemid 44148112)
294. Ueno N, Takeya R, Miyano K, Kikuchi H, and Sumimoto H. The NADPH oxidase Nox3 constitutively produces su-peroxide in a p22phox-dependent manner: its regulation by oxidase organizers and activators. J Biol Chem 280: 23328-23339, 2005. (Pubitemid 40853246)
295. Ukai H and Ueda HR. Systems biology of mammalian circadian clocks. Annu Rev Physiol 72: 579-603, 2010.
296. Ushio-Fukai M. VEGF signaling through NADPH oxidase-derived ROS. Antioxid Redox Signal 9: 731-739, 2007. (Pubitemid 46799105)
297. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, and Griendling KK. p22phox is a critical component of the su-peroxide-generating NADH/NADPH oxidase system and regulates angiotensin II-induced hypertrophy in vascular smooth muscle cells. J Biol Chem 271: 23317-23321, 1996. (Pubitemid 26314775)
298. Vander Heiden MG, Cantley LC, and Thompson CB. Un-derstanding the Warburg effect: the metabolic require-ments of cell proliferation. Science 324: 1029-1033, 2009.
299. VanDuijn MM, Van der Zee J, and Van den Broek PJ. The ascorbate-driven reduction of extracellular ascorbate free radical by the erythrocyte is an electrogenic process. FEBS Lett 491: 67-70, 2001.
300. Vernet P, Fulton N, Wallace C, and Aitken RJ. Analysis of reactive oxygen species generating systems in rat epididy-mal spermatozoa. Biol Reprod 65: 1102-1113, 2001. (Pubitemid 32927575)
301. Villalba JM, Navarro F, Córdoba F, Serrano A, Arroyo A, Crane FL, and Navas P. Coenzyme Q reductase from liver plasma membrane: purification and role in trans-plasma-membrane electron transport. Proc Natl Acad Sci USA 92: 4887-4891, 1995.
302. Villalba JM, Navarro F, Gomez-Díaz C, Arroyo A, Bello RI, and Navas P. Role of cytochrome b5 reductase on the an-tioxidant function of coenzyme Q in the plasma membrane. Mol Aspects Med 18: S7-S13, 1997.
303. Viora M, Quaranta MG, Straface E, Vari R, Masella R, and Malorni W. Redox imbalance and immune functions: op-posite effects of oxidized low-density lipoproteins and N-acetylcysteine. Immunology 104: 431-438, 2001. (Pubitemid 34037836)
304. Voegtlin C, Johnson JM, and Dyer HA Jr. Quantitative es-timation of the reducing power of normal and cancer tis-sue. J Pharmacol Exp Ther 24: 305-334, 1925.
305. Wang C and Youle RJ. The role of mitochondria in apo-ptosis. Annu Rev Genet 43: 95-118, 2009.
306. Wang HM, Chueh PJ, Chang SP, Yang CL, and Shao KN. Effect of capsaicin on tNOX (ENOX2) protein expression in stomach cancer cells. Biofactors 34: 209-217, 2009.
307. Wang S, Morré DM, and Morré DJ. Sera from cancer pa-tients contain two oscillating ECTO-NOX activities with different period lengths. Cancer Lett 190: 135-141, 2003. (Pubitemid 36136011)
308. Wang S, Pogue R, Morré DM, and Morré DJ. NADH oxi-dase activity (NOX) and enlargement of HeLa cells oscillate with two different temperature-compensated period lengths of 22 and 24 minutes corresponding to different NOX forms. Biochim Biophys Acta 1539: 192-204, 2001. (Pubitemid 32566216)
309. Warburg O. (Eds). The Metabolism of Tumors. London Constable & Co, 1930.
310. Wesley UV, Bove PF, Hristova M, McCarthy S, and van der Vliet A. Airway epithelial cell migration and wound repair by ATP-mediated activation of dual oxidase 1. J Biol Chem 282: 3213-3220, 2007. (Pubitemid 47084365)
311. Wilkinson F, Kim C, Cho N, Chueh P-J, Leslie S, Moya-Camarena S, Wu L-Y, Morré DJ, and Morré DM. Isolation and identification of a protein with capsaicin-inhibited NADHoxidase activity from culture media conditioned by growth of HeLa cells. Arch Biochem Biophys 336: 275-282, 1996. (Pubitemid 26428242)
312. Wolvetang EJ, Larm JA, Moutsoulas P, and Lawen A. Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ 7: 1315-1325, 1996. (Pubitemid 26360680)
313. Wong JL, Créton R, and Wessel GM. The oxidative burst at fertilization is dependent upon activation of the dual oxi-dase Udx1. Dev Cell 7: 801-814. 2004. (Pubitemid 39654726)
314. Wyman S, Simpson RJ, McKie AT, and Sharp PA. Dcytb (Cybrd1) functions as both a ferric and a cupric reductase in vitro. FEBS Lett 582: 1901-1906, 2008.
315. Yagiz K, Wu LY, Kuntz CP, James Morré D, and Morré DM. Mouse embryonic fibroblast cells from transgenic mice overexpressing tNOX exhibit an altered growth and drug response phenotype. J Cell Biochem 101: 295-306, 2007. (Pubitemid 46698865)
316. Yantiri F, Morré DJ, Yagiz K, Barogi S, Wang S, Chueh PJ, Cho N, Sedlak D, and Morré DM. Capsaicin-responsive NADH oxidase activities from urine of cancer patients. Arch Biochem Biophys 358: 336-342, 1998. (Pubitemid 28480953)
317. Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological conse-quences. Antioxid Redox Signal 10: 179-206, 2008.
318. Zaid H, Abu-Hamad S, Israelson A, Nathan I, and Shoshan-Barmatz V. The voltage-dependent anion channel-1 mod-ulates apoptotic cell death. Cell Death Differ 12: 751-760, 2005. (Pubitemid 40945982)
319. Zainal TA, Oberley TD, Allison DB, Szweda LI, and Weindruch R Caloric restriction of rhesus monkeys lowers oxidative damage in skeletal muscle. FASEB J 14: 1825-1836, 2000.
320. Zalba G, Beaumont FJ, San Jose G, Fortuno A, Fortuno MA, Etayo JC, and Diez J. Vascular NADH/NADPH ox-idase is involved in enhanced superoxide production in spontaneously hypertensive rats. Hypertension 35: 1055-1061, 2000. (Pubitemid 30327257)
321. Zalba G, San José G, Moreno MU, Fortuño A, and D́ez J. NADPH Oxidase-mediated oxidative stress: genetic studies of the p22phox gene in hypertension. Antioxid Redox Signal 7: 1327-1336, 2005. (Pubitemid 41232530)
322. Zhan S, Vazquez N, Zhan S, Wientjes FB, Budarf ML, Schrock E, Ried T, Green ED, and Chanock SJ. Genomic structure, chromosomal localization, start of transcrip-tion, and tissue expression of the human p40-phox, a new component of the nicotinamide adenine dinucleo-tide phosphate-oxidase complex. Blood 88: 2714-2721, 1996. (Pubitemid 26327525)
323. Zhang Z, Yu J, and Stanton RC. A method for determina-tion of pyridine nucleotides using a single extract. Anal Biochem 285: 163-167, 2000.